Cresco Labs (CRLBF) Other Non-Current Liabilities (2019 - 2026)

Cresco Labs (CRLBF) posted Other Non-Current Liabilities of $184.9 million for Q1 2026, up 7.83% on a QoQ basis from $171.5 million in Q4 2025, and up 36.15% year-over-year from $135.8 million in Q1 2025.

Cresco Labs (CRLBF) Other Non-Current Liabilities (2019 - 2026) Analysis & Trends

Cresco Labs' Other Non-Current Liabilities history runs 8 years deep, the most recent figure standing at $184.9 million for Q1 2026.

  • Quarterly Other Non-Current Liabilities rose 36.15% year-over-year to $184.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $184.9 million (up 36.15% YoY) and the FY2025 annual result came in at $171.5 million, changed N/A from the prior year.
  • Other Non-Current Liabilities was $184.9 million for Q1 2026 at Cresco Labs, up from $171.5 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $184.9 million in Q1 2026 and bottomed at $7.0 million in Q1 2022.
  • A 5-year average of $97.2 million and a median of $136.2 million in 2024 frame the typical range for Other Non-Current Liabilities.
  • Annual changes were most pronounced in 2022 — Other Non-Current Liabilities slipped 18.14% — and 2025, when it jumped 522.14%.
  • Cresco Labs' Other Non-Current Liabilities stood at $12.9 million in 2022, then jumped by 56.67% to $20.2 million in 2023, then jumped by 658.94% to $153.4 million in 2024, then rose by 11.79% to $171.5 million in 2025, then climbed by 7.83% to $184.9 million in 2026.
  • Business Quant data shows CRLBF's Other Non-Current Liabilities at $184.9 million in Q1 2026, $171.5 million in Q4 2025, and $165.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Cresco Labs 254.96 Mn 99.57 Mn 75.45 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 184.91 Mn
Dec 31, 2025 171.47 Mn
Sep 30, 2025 165.16 Mn
Jun 30, 2025 150.54 Mn
Mar 31, 2025 135.81 Mn
Sep 30, 2024 153.40 Mn
Jun 30, 2024 136.64 Mn
Mar 31, 2024 21.83 Mn
Dec 31, 2023 20.21 Mn
Dec 31, 2022 12.90 Mn
Jun 30, 2022 7.01 Mn
Mar 31, 2022 7.01 Mn
Dec 31, 2021 7.00 Mn
Sep 30, 2021 7.04 Mn
Mar 31, 2021 8.56 Mn
Dec 31, 2020 8.56 Mn
Dec 31, 2019 15.41 Bn